Cardax Pharma
Honolulu
About Cardax Pharma
Cardax Pharmaceuticals develops proprietary small molecule therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles’including dyslipidemia, metabolic disease, arthritis, cardiovascular disease, hepatitis, macular degeneration, and many others. Most anti-inflammatory drugs have significant safety and side effect issues that limit their utility. In contrast, the company’s proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers robust efficacy combined with exceptional safety, oral bioavailability, and tissue selectivity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2017)
- Ticker: otcqb:CDXI
- Website: cardaxpharma.com
- Phone: (808) 457-1400
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cardax-pharma-2236414 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.